Donor-derived oral squamous cell carcinoma after allogeneic bone marrow transplantation

Blood

Volumn 113, Issue 8, 2009, Pages 1834-1840

  Janin, Anne ^a,b,c   Murata, Hideyuki ^a,b,c   Leboeuf, Christophe ^a,b   Cayuela, Jean Michel ^a,b,d   Gluckman, Eliane ^b,c   Legrès, Luc ^a,b   Desveaux, Allison ^a,b   Varna, Mariana ^a,b   Ratajczak, Philippe ^a,b   Soulier, Jean ^a,b,d   De Thé, Hugues ^b,c,e   Bertheau, Philippe ^a,b,c   Socié, Gérard ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DIDEROT   (France)

^c SAINT LOUIS HOSPITAL   (France)

^d Laboratoire Central d'Hematologie   (France)

^e CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; HYDROXYUREA; METHOTREXATE; MICROSATELLITE DNA; STEROID; THYMOCYTE ANTIBODY;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ALLOTRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; BONE MARROW CELL; CANCER GROWTH; CANCER SURVIVAL; CARCINOGENESIS; CASE REPORT; CELL FATE; CELL FUSION; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; ENGRAFTMENT; EPITHELIUM TUMOR; FANCONI ANEMIA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LASER MICRODISSECTION; LICHENOID; MALE; MESENCHYME CELL; MOUTH CARCINOMA; MUCOSA INFLAMMATION; ORGAN DONOR; PRESCHOOL CHILD; PRIORITY JOURNAL; RECIPIENT; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME; T CELL DEPLETION; X CHROMOSOME; Y CHROMOSOME;

EID: 61849102824     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-07-171702     Document Type: Article

References (40)

1. Curtis RE, Metayer C, Rizzo JD, et al. Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stemcell transplantation: an international case-control study. Blood. 2005;105:3802-3811.
2. Socie G, Henry-Amar M, Bacigalupo A, et al. Malignant tumors occurring after treatment of aplas-tic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party. N Engl J Med. 1993;329:1152-1157.
3. Korbling M, Katz RL, Khanna A, et al. Hepato-cytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells. N Engl J Med. 2002;346:738-746.
4. Krause DS, Theise ND, Collector MI, et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell. 2001;105:369-377.
5. Wagers AJ, Sherwood RI, Christensen JL, Weissman IL. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science. 2002;297:2256-2259.
6. Wurmser AE, Gage FH. Stem cells: cell fusion causes confusion. Nature. 2002;416:485-487.
7. Burt RK, Loh Y, Pearce W, et al. Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases. JAMA. 2008; 299:925-936.
8. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143-147.
9. Flynn CM, Kaufman DS. Donor cell leukemia: insight into cancer stem cells and the stem cell niche. Blood. 2007;109:2688-2692.
10. Avital I, Moreira AL, Klimstra DS, et al. Donor-derived human bone marrow cells contribute to solid organ cancers developing after bone marrow transplantation. Stem Cells. 2007;25:2903-2909.
11. Cogle CR, Theise ND, Fu D, et al. Bone marrow contributes to epithelial cancers in mice and humans as developmental mimicry. Stem Cells. 2007;25:1881-1887.
12. Houghton J, Stoicov C, Nomura S, et al. Gastric cancer originating from bone marrow-derived cells. Science. 2004;306:1568-1571.
13. Lishner M, Patterson B, Kandel R, et al. Cutaneous and mucosal neoplasms in bone marrow transplant recipients. Cancer. 1990;65:473-476.
14. Socie G, Scieux C, Gluckman E, et al. Squamous cell carcinomas after allogeneic bone marrow transplantation for aplastic anemia: further evidence of a multistep process. Transplantation. 1998;66:667-670.
15. Meignin V, Soulier J, Brau F, et al. Little evidence of donor-derived epithelial cells in early digestive acute graft-versus-host disease. Blood. 2004; 103:360-362.
16. Murata H, Janin A, Leboeuf C, et al. Donor-derived cells and human graft-versus-host disease of the skin. Blood. 2007;109:2663-2665.
17. Peters BA, Diaz LA, Polyak K, et al. Contribution of bone marrow-derived endothelial cells to human tumor vasculature. Nat Med. 2005;11:261-262.
18. Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med. 1980;69:204-217.
19. Saurat JH, Gluckman E. Lichen-planus-like eruption following bone marrow transplantation: a manifestation of the graft-versus-host disease. Clin Exp Dermatol. 1977;2:335-344.
20. Janin-Mercier A, Saurat JH, Bourges M, Sohier J, Jean LD, Gluckman E. The lichen planus like and sclerotic phases of the graft versus host disease in man: an ultrastructural study of six cases. Acta Derm Venereol. 1981;61:187-193.
21. Eady RA, Cowen T. Epidermal repair in lichen planus: a light and electron microscopical study. Clin Exp Dermatol. 1977;2:323-334.
22. Marks R, Black M, Jones EW. Epidermal cell kinetics in lichen planus. Br J Dermatol. 1973;88: 37-45.
23. Guardiola P, Socie G, Li X, et al. Acute graft-versus-host disease in patients with Fanconi anemia or acquired aplastic anemia undergoing bone marrow transplantation from HLA-identical sibling donors: risk factors and influence on outcome. Blood. 2004;103:73-77.
24. Rosenberg PS, Socie G, Alter BP, Gluckman E. Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants. Blood. 2005;105:67-73.
25. Faber P, Fisch P, Waterhouse M, et al. Frequent genomic alterations in epithelium measured by microsatellite instability following allogeneic he-matopoietic cell transplantation in humans. Blood. 2006;107:3389-3396.
26. Beachy PA, Karhadkar SS, Berman DM. Tissue repair and stem cell renewal in carcinogenesis. Nature. 2004;432:324-331.
27. Okamoto R, Yajima T, Yamazaki M, et al. Damaged epithelia regenerated by bone marrow-derived cells in the human gastrointestinal tract. Nat Med. 2002;8:1011-1017.
28. Collin MP, Hart DN, Jackson GH, et al. The fate of human Langerhans cells in hematopoietic stem cell transplantation. J Exp Med. 2006;203: 27-33.
29. Prockop DJ, Olson SD. Clinical trials with adult stem/progenitor cells for tissue repair: let's not overlook some essential precautions. Blood. 2007;109:3147-3151.
30. Berg D, Otley CC. Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management. JAm Acad Dermatol. 2002;47:1-17, quiz 18-20.
31. Rubel JR, Milford EL, Abdi R. Cutaneous neoplasms in renal transplant recipients. Eur J Der-matol. 2002;12:532-535.
32. Aractingi S, Kanitakis J, Euvrard S, et al. Skin carcinoma arising from donor cells in a kidney transplant recipient. Cancer Res. 2005;65:1755-1760.
33. Deeg HJ, Socie G. Malignancies after hematopoi-etic stem cell transplantation: many questions, some answers. Blood. 1998;91:1833-1844.
34. Hossain MS, Roback JD, Pollack BP, Jaye DL, LangstonA, Waller EK. Chronic GvHD decreases antiviral immune responses in allogeneic BMT. Blood. 2007;109:4548-4556.
35. Adhikary D, Behrends U, Moosmann A, Witter K, Bornkamm GW, Mautner J. Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins. J Exp Med. 2006;203:995-1006.
36. Arai Y, Arai H, Aoyagi A, et al. A solid tumor of donor cell-origin after allogeneic peripheral blood stem cell transplantation. Am J Transplant. 2006; 6:3042-3043.
37. Pawelek JM, Chakraborty AK. Fusion of tumour cells with bone marrow-derived cells: a unifying explanation for metastasis. Nat Rev Cancer. 2008;8:377-386.
38. Imanishi D, Miyazaki Y, Yamasaki R, et al. Donor-derived DNA in fingernails among recipients of allogeneic hematopoietic stem-cell transplants. Blood. 2007;110:2231-2234.
39. Flemming P, Tillmann HL, Barg-Hock H, et al. Donor origin of de novo hepatocellular carcinoma in hepatic allografts. Transplantation. 2003;76:1625-1627.
40. Friedman DL, Alicia Rovo A, Leisenring W, et al. Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party. Blood. 2008;111:939-944.